Clinical Trial Update: Ibrutinib, Nivolumab and Blinatumomab in Richter Transformation [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a combination of ibrutinib, nivolumab, and blinatumomab in Richter transformation has been terminated; results posted previously. No ne…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematopoietic Lymphoid Cancer
• Richter Transformation

Drugs mentioned

• Blinatumomab (blinatumomab)
• Ibrutinib (ibrutinib)
• nivolumab (nivolumab)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Hematopoietic/Lymphoid Cancer, Richter's Transformation | Phase 2 | Status: TERMINATED | Results posted: 2023-02-17